La Biblioteca le brinda un dossier informativo actualizado sobre Coronavirus (COVID-19)

Ministerio de Salud: Recomendaciones

 

Organización Panamericana de la Salud (OPS) – Argentina / CDC

OPS: cursos sobre COVID-19 en español

OPS Recursos de información relacionados con el nuevo coronavirus

Vitrina del conocimiento: Nuevo coronavirus

CDC –  Centros para el Control y la Prevención de Enfermedades – USA Recomendaciones, cómo protegerse

 

Sociedades científicas: Recursos

VACUNAS CONTRA LA COVID-19. Coadministración con otras vacunas

http://www.colfarma.info/colfarma/wp-content/uploads/2021/03/Boletin-ESPECIAL-01-03-2021-IMPORTANTE-VACUNAS-CONTRA-LA-COVID-19-Coadministracion-con-otras-vacunas.htm

ALERTA DE LA RPVF 22/02/2021 Sinopharm

http://www.colfarma.info/colfarma/alerta-de-la-rpvf-22-02-2021-sinopharm/

ALERTA DE LA RPVF 18/02/2021 Vacuna Sputnik V: Nueva presentación del Componente 1

http://www.colfarma.info/colfarma/alerta-de-la-rpvf-18-02-2021-vacuna-sputnik-v-nueva-presentacion-del-componente-1/

ALERTA DE LA RPVF 11/02/2021 SPUTNIK V: ACTUALIZACIÓN SOBRE SITUACIONES ESPECIALES EN LA POBLACIÓN OBJETIVO A VACUNAR

http://www.colfarma.info/colfarma/alerta-de-la-rpvf-11-02-2021-sputnik-v-actualizacion-sobre-situaciones-especiales-en-la-poblacion-objetivo-a-vacunar/

Sexto Informe de seguridad en vacunas. Vacunación COVID-19 en Argentina

https://bancos.salud.gob.ar/sites/default/files/2021-02/6to-informe-seguridad-en-vacunas-09_02.pdf

Lineamientos técnicos para la Campaña Nacional de Vacunación contra la COVID-19

https://bancos.salud.gob.ar/sites/default/files/2020-12/covid19-lineamientos-tecnicos-para-campania-nacional-de-vacunacion-contra-covid19.pdf

Comunicación sobre datos preliminares de seguridad de vacunas que se están administrando en países de la Región. (20/01/21)

http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/01/ESP-Nota-seguridad-de-vacunas-I.pdf

Resumen inicial de ESAVIs reportados para vacunas que se están utilizando en países de la Región.(19/01/21)

http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/01/ESP-tablas-sobre-seguridad-de-vacunas.pdf

Sputnik V: actualización de las condiciones para la conservación y uso de la vacuna

http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/02/Memo-SPUNTIK-V-3.2.2021.pdf

Evaluación del riesgo por contagio de coronavirus SARS-CoV-2 y medidas preventivas recomendadas en la prestación de servicios profesionales farmacéuticos asistenciales (SPFA)

https://www.sefac.org/system/files/2020-06/Documento%20SEFAC%20evaluaci%C3%B3n%20de%20riesgos%20en%20SPFA%20y%20coronavirus_0.pdf

AEMPS: 1º Informe de Farmacovigilancia sobre vacunas COVID-19 (25-01-2021)

https://www.aemps.gob.es/la-aemps/ultima-informacion-de-la-aemps-acerca-del-covid%E2%80%9119/vacunas-contra-la-covid%E2%80%9119/1o-informe-de-farmacovigilancia-sobre-vacunas-covid-19-25-01-2021/

Seguridad y eficacia preliminar de las vacunas para la prevención de COVID-19

http://www.evidencia.org/index.php/Evidencia/article/view/6912/4503

Autorización con carácter de emergencia: vacuna COVISHIELD/ ChAdOx1nCoV-19 Corona Virus Vaccine – Recombinant

https://www.boletinoficial.gob.ar/detalleAviso/primera/240575/20210209

VACUNAS CONTRA COVID-19

https://www.iecs.org.ar/wp-content/uploads/IECS-IRR-818-VA-Vacuna-covid-1.pdf

Recomendaciones para el USO CON FINES TERAPÉUTICOS DE INMUNOGLOBULINAS EQUINAS FRAGMENTOS F (ab´)2 ANTI SARS-CoV-2 EN COVID-19

http://cime.fcq.unc.edu.ar/recomendaciones-para-el-uso-con-fines-terapeuticos-de-inmunoglobulinas-equinas-fragmentos-f-ab2-anti-sars-cov-2-en-covid-19/

Actualización ficha técnica RACIM de ivermectina (versión 3)

http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/02/RACIM-Ivermectina-ficha-t%C3%A9cnica-v.3-01-02-21.pdf

Novel Coronavirus 2019, Actualización 11-01-2021 – Representación OPS/OMS Argentina

https://www.paho.org/es/documentos/novel-coronavirus-2019-actualizacion-11-01-2021-representacion-opsoms-argentina?utm_source=Boletines+ARG+%28A+su+salud%2C+Comunicados%2C+COVID-19%29&utm_campaign=aa7606df38-EMAIL_CAMPAIGN_2020_05_07_08_26_COPY_01&utm_medium=email&utm_term=0_f076a74c17-aa7606df38-111563993

COVID-19: INFORMACIÓN SOBRE PLATAFORMAS DE VACUNAS

http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/01/Informe-RACIM-COVID19-Plataformas-de-vacunas.pdf

Vacuna contra coronavirus: No está comprobado que todos Los pacientes que hayan tenido una reacción alérgica grave deban evitar la vacunación

http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2020/12/Gacetilla-Vacuna-Covid19-AAAeIC-AAAIC.pdf

Mitos y verdades sobre la vacunación COVID-19 en Argentina

http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2020/12/Mitos-y-Verdades-COVID-19-vacunas-Min-Salud-nov-2020.pdf

Therapeutics and COVID‐19

https://bit.ly/35LyEH6

COVID-19: Recomendaciones para calefacción, ventilación y aire acondicionado en establecimientos de salud

https://www.paho.org/es/documentos/covid-19-recomendaciones-para-calefaccion-ventilacion-aire-acondicionado¿

Ventilación y COVID-19 en la Industria

https://www.argentina.gob.ar/sites/default/files/ficha_tecnica_ventilacion_y_covid_150920.pdf

Infografía: Resistencia a los Antimicrobianos y COVID-19

https://www.paho.org/es/documentos/infografia-resistencia-antimicrobianos-covid-19

COVID-19: Acciones regulatorias de ANMAT

https://www.argentina.gob.ar/anmat/covid-19-acciones-regulatorias-de-anmat

PROTOCOLO DE ACTUACIÓN DESDE LAS FARMACIAS COMUNITARIAS

https://www.colfacor.org.ar/administrador_web/kcfinder/upload/files/info_coronavirus_farmacias%284%29.pdf

Impacto de los sistemas de ventilación en la transmisión del SARSCoV2Recomendaciones generales para los edificios de uso público

https://www.comunidad.madrid/sites/default/files/doc/sanidad/samb/doc_tec_ventilacion_el_sars-cov-2.pdf

Ivermectina para el tratamiento y/o profilaxis de COVID-19

https://www.sadi.org.ar/novedades/documentos-de-posicion/item/1329-ivermectina-para-el-tratamiento-y-o-profilaxis-de-covid-19

Una actualización de la investigación de las vacunas contra COVID-19 y otras consideraciones como el monitoreo de eventos adversos, la transparencia y la calidad de la investigación clínica.

http://www.proyectodime.info/informacion-regional/informacion-seleccionada-sobre-covid-19/boletines/una-actualizacion-de-la-investigacion-de-las-vacunas-contra-covid-19-y-otras-consideraciones-como-el-monitoreo-de-eventos-adversos-la-transparencia-y-la-calidad-de-la-investigacion-clinica/

Draft landscape of COVID-19 candidate vaccines
https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

Global research on coronavirus disease (COVID-19)
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov

Materiales para equipos de salud – Ministerio de Salud de la Nación
http://www.msal.gob.ar/index.php/component/bes_contenidos/?filter_problematica=100&filter_soporte=0&start=60

COVID-19INTERACCIONES MEDICAMENTOSAS
https://www.argentina.gob.ar/sites/default/files/covid-19_interacciones-medicamentosas.pdf

Aspectos de Bioseguridad. Pandemia COVID-19 – SARS-CoV-2 Subcomisión de Bioseguridad y Biocustodia, Asociación Argentina de Microbiología
https://www.aam.org.ar/src/img_up/29032020.0.pdf

COVID-19 resúmenes de artículos en español. Sociedad Iberoamericana de Información Científica
https://www.siicsalud.com/

Repositorio COVID-19 (ITAES)
https://www.itaes.org.ar/RepositorioCOVID19.aspx?secId=81

 

Artículos científicos

Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine

https://bit.ly/3txtx75

Decontaminating N95 respirators during the COVID-19 pandemic: simple and practical approaches to increase decontamination capacity, speed, safety and ease of use

https://www.journalofhospitalinfection.com/article/S0195-6701(20)30570-3/pdf

Decontamination of common healthcare facility surfaces contaminated with SARS-CoV-2 using peracetic acid dry fogging

https://www.journalofhospitalinfection.com/article/S0195-6701(20)30581-8/pdf

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study

https://www.bmj.com/content/bmj/372/bmj.n311.full.pdf

FLCC. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

https://osf.io/wx3zn/?fbclid=IwAR0r7JRRaG4yQ08EiOrJFw2GA0Lkc2sL3eSTj9Bjkp_-BZYNi5saLVk8EAo

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30464-8/fulltext

Drug interactions for elderly with respiratory disorders and times of COVID-19: a systematic scoping review

https://revistas.udea.edu.co/index.php/vitae/article/view/343796/20804337

Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19

https://www.medrxiv.org/content/10.1101/2021.01.26.21250494v1

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

https://bit.ly/3rezvI5

Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”

https://www.repositoriosalud.es/bitstream/10668/3215/1/Entrenas_EffectOfCalcifediol.pdf

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

https://bit.ly/3avhKxD

Severe sinus bradycardia associated with Remdesivir in a child with severe SARS-CoV-2 infection

https://link.springer.com/article/10.1007/s00431-021-03940-4

From Hydroxychloroquine to Ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?

https://academic.oup.com/jtm/advance-article/doi/10.1093/jtm/taab005/6106246

Focus on COVID-19: Antiviral polymers in drugs and vaccines

https://www.polimery.umed.wroc.pl/pdf/2020/50/2/75.pdf

Quinacrine, an Antimalarial Drug with Strong Activity Inhibiting SARS-CoV-2 Viral Replication In Vitro

https://www.mdpi.com/1999-4915/13/1/121/pdf

Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection

https://www.researchsquare.com/article/rs-148845/v1

Excipients as potential agents of anaphylaxis in vaccines: analyzing the formulations of the current authorized COVID-19 vaccines

http://www.jiaci.org/revistas/doi10.18176_jiaci.0667.pdf

Allergic reactions to COVID-19 -vaccinations – unveiling the secret(s)

https://onlinelibrary.wiley.com/doi/epdf/10.1111/all.14734

La Quercetina como un potencial nutracéutico contra la enfermedad por coronavirus 2019 (COVID-19)

https://revistaseug.ugr.es/index.php/ars/article/view/15684/15561

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A

https://science.sciencemag.org/content/early/2021/01/22/science.abf4058/tab-pdf

Potential beneficial role of probiotics on the outcome of COVID-19 patients: An evolving perspective

https://www.sciencedirect.com/science/article/pii/S187140212030535X?via%3Dihub

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

https://bit.ly/3quNVV9

mRNA-1273 Study Group. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

https://bit.ly/39U0iE9

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

https://bit.ly/2VTyXd9

Safety and efficacy of the BNT162b2 Covid-19 vaccine

https://bit.ly/3m4YeeY

Manifestações Cutâneas Associadas à COVID-19: Uma Revisão Narrativa

https://actamedicaportuguesa.com/revista/index.php/amp/article/view/14574/6218

Clinical and Pathogenic Correlations Between SARS-CoV-2 Infection and Hemolytic Uremic Syndrome in Children

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726516/pdf/maedica-15-376.pdf

Administration of intravenous immunoglobulin in the treatment of COVID‐19: a review of available evidence

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26727

Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection

https://www.sciencedirect.com/science/article/pii/S0169409X20302775?via%3Dihub

Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro

https://www.sciencedirect.com/science/article/pii/S0024320520316428?via%3Dihub

Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System

https://www.ackdjournal.org/article/S1548-5595(20)30112-9/fulltext

A systematic review of possible airborne transmission of the COVID-19 virus (SARS-CoV-2) in the indoor air environment

https://www.sciencedirect.com/science/article/pii/S0013935120315097?via%3Dihub

Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19?

https://www.maturitas.org/article/S0378-5122(20)30346-7/fulltext

Vitamin C—An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19

https://www.mdpi.com/2072-6643/12/12/3760/pdf

Vaccinating Pregnant and Lactating Patients Against COVID-19

https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/vaccinating-pregnant-and-lactating-patients-against-covid-19

Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19

https://jamanetwork.com/journals/jama/fullarticle/2773516

Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry

https://www.tandfonline.com/doi/abs/10.1080/07853890.2020.1836566

Review of registered clinical trials for the treatment of COVID‐19

https://onlinelibrary.wiley.com/doi/10.1002/ddr.21762

Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19

https://journals.lww.com/eurojgh/Abstract/9000/Pre_hospitalization_proton_pump_inhibitor_use_and.97360.aspx

Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications

https://www.tandfonline.com/doi/full/10.1080/17512433.2021.1856655

Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study

https://www.tandfonline.com/doi/full/10.1080/17476348.2021.1856659

JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality

https://advances.sciencemag.org/content/early/2020/11/13/sciadv.abe4724.full

A Nursing Researcher’s Experience in a COVID-19 Vaccine Trial

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2773790

Ongoing Living Update of Potential COVID-19 Therapeutics: Summary of Rapid Systematic Reviews. Rapid Review

https://bit.ly/37fsZZm

Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications

https://bit.ly/2JyBXbM

Reacciones adversas a fármacos utilizados en el tratamiento específico de la infección por SARS‐CoV‐2

https://www.elsevier.es/es‐revista‐medicina‐clinica‐2‐articulo‐reacciones‐adversas‐farmacos‐utilizados‐el‐S0025775320304425

Hospital Radiopharmacy in Argentina during the COVID‐19 pandemic. Criteria and rationale for the organization of work

https://www.sciencedirect.com/science/article/pii/S2253654X20301712?via%3Dihub

A Randomized Trial of Convalescent Plasma in Covid‐19 Severe Pneumonia

https://www.nejm.org/doi/full/10.1056/NEJMoa2031304?query=featured_home

Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID‐19 patients: results from a randomized controlled clinical trial

https://erj.ersjournals.com/content/erj/early/2020/09/09/13993003.02808‐2020.full.pdf

Successful Treatment of a COVID‐19 Case with Pneumonia and Renal Injury Using Tocilizumab

https://www.mdpi.com/2571‐841X/3/4/29/htm

SARS‐CoV‐2 immunity: review and applications to phase 3 vaccine candidates

https://www.sciencedirect.com/science/article/pii/S0140673620321371/pdfft?isDTMRedir=true&download=true

A pilot study on the preventative potential of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 transmission

https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/10817/9289

Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead

https://www.sciencedirect.com/science/article/pii/S0014299920308098/pdfft?isDTMRedir=true&download=true

SARS-CoV-2 and inflammatory responses: from mechanisms to the potential therapeutic use of intravenous immunoglobulin

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26651

COVID-19 et vaccination : une dérégulation globale

https://www.medecinesciences.org/en/articles/medsci/pdf/2020/10/msc200259.pdf

Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy

https://link.springer.com/article/10.1007/s40266-020-00812-8

Could ozone be an effective disinfection measure against the novel coronavirus (SARS-CoV-2)?

https://www.jpmh.org/index.php/jpmh/article/view/1596/776

Sitagliptin: a potential drug for the treatment of COVID-19?

https://hrcak.srce.hr/index.php?show=clanak&id_clanak_jezik=344935&lang=en

Safety and efficacy of Artemisinin-Piperaquine for treatment of COVID-19: an open-label, non-randomized, and controlled trial

https://www.sciencedirect.com/science/article/pii/S0924857920304271?via%3Dihub

Pharmacotherapy for Hospitalized Patients with COVID-19: Treatment Patterns by Disease Severity

https://link.springer.com/article/10.1007%2Fs40265-020-01424-7

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans

https://science.sciencemag.org/content/sci/early/2020/11/05/science.abe1107.full.pdf

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2931866-3

Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply

https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2931970-X

Efficacy and safety of disinfectants for decontamination of N95 and SN95 filtering facepiece respirators: a systematic review

https://www.journalofhospitalinfection.com/article/S0195-6701(20)30383-2/fulltext?dgcid=raven_jbs_etoc_email

Microwave- and heat-based decontamination of N95 filtering facepiece respirators: a systematic review

https://www.journalofhospitalinfection.com/article/S0195-6701(20)30403-5/fulltext?dgcid=raven_jbs_etoc_email

The use of germicidal ultraviolet light, vaporized hydrogen peroxide and dry heat to decontaminate face masks and filtering respirators contaminated with a SARS-CoV-2 surrogate virus

https://www.journalofhospitalinfection.com/article/S0195-6701(20)30413-8/fulltext?dgcid=raven_jbs_etoc_email

Unintended consequences of long-sleeved gowns in a critical care setting during the COVID-19 pandemic

https://www.journalofhospitalinfection.com/article/S0195-6701(20)30367-4/fulltext?dgcid=raven_jbs_etoc_email

Laundering single-use gowns in the event of critical shortage: experience of a UK acute trust

https://www.journalofhospitalinfection.com/article/S0195-6701(20)30404-7/fulltext?dgcid=raven_jbs_etoc_email

Rapid SARS-CoV-2 inactivation by commonly available chemicals on inanimate surfaces

https://www.journalofhospitalinfection.com/article/S0195-6701(20)30415-1/fulltext?dgcid=raven_jbs_etoc_email

2019 Novel Coronavirus (COVID-19) Pandemic: BuiltEnvironment Considerations To Reduce Transmission

https://msystems.asm.org/content/msys/5/2/e00245-20.full.pdf

Association of SARS-CoV-2 Genomic Load with COVID-19 Patient Outcomes

https://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.202008-931RL

The Potential Therapeutic Role of Proton Pump Inhibitors in COVID-19: Hypotheses Based on Existing Evidences

https://www.thieme-connect.de/products/ejournals/html/10.1055/a-1236-3041

Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239799

Natural compounds as inhibitors of SARS-CoV-2 endocytosis: A promising approach against COVID-19

https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/10520/9312